Index of reports
> Cases with Death (12)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Mycamine (Micafungin) where reactions include death. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Mycamine side effects in female
Reported by a physician from United States on 2012-07-17
Patient: female
Reactions: Off Label Use, Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Mycamine
Possible Mycamine side effects in male
Reported by a physician from United States on 2012-06-22
Patient: male
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Mycamine
Other drugs received by patient: Levalbuterol HCL; Propofol; Sodium Bicarbonate; Levophed; Norepinephrine Bitartrate; Morphine; Sodium Chloride
Possible Mycamine side effects in female
Reported by a consumer/non-health professional from United States on 2012-06-20
Patient: female
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Mycamine
Possible Mycamine side effects in male
Reported by a consumer/non-health professional from United States on 2012-05-30
Patient: male
Reactions: Off Label Use, Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Mycamine
Possible Mycamine side effects in
Reported by a consumer/non-health professional from United States on 2012-05-25
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Mycamine
Possible Mycamine side effects in female
Reported by a consumer/non-health professional from United States on 2012-05-16
Patient: female
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Mycamine
Possible Mycamine side effects in male
Reported by a consumer/non-health professional from United States on 2012-04-09
Patient: male, weighing 99.0 kg (217.8 pounds)
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Prograf
Dosage: 1 mg, tid
Administration route: Oral
Indication: Liver Transplant
Start date: 2006-10-28
End date: 2012-03-30
Mycamine
Dosage: 100 mg, uid/qd
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Methylprednisolone; Gentamicin; Calcium Chloride; Lansoprazole; Ribavirin; Doripenem; Norepinephrine Bitartrate; Ursodiol; Daptomycin
Possible Mycamine side effects in 79 year old female
Reported by a consumer/non-health professional from United States on 2012-03-15
Patient: 79 year old female
Reactions: Death, Renal Failure, Contusion, Blood Lactate Dehydrogenase Increased, Thrombotic Thrombocytopenic Purpura
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Mycamine
Possible Mycamine side effects in male
Reported by a consumer/non-health professional from United States on 2012-01-18
Patient: male
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Mycamine
Possible Mycamine side effects in female
Reported by a consumer/non-health professional from United States on 2011-12-06
Patient: female, weighing 68.0 kg (149.6 pounds)
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Mycamine
Other drugs received by patient: Ativan; Sodium Chloride; Morphine; Dopamine HCL; Calcium Chloride; Tygacil; Guaifenesin; Lortab; Vasopressin
Possible Mycamine side effects in 40 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2011-11-30
Patient: 40 year old male
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Mycamine
Possible Mycamine side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-14
Patient: female
Reactions: Abdominal Pain, Death, Chills, Infusion Related Reaction
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Mycamine
Dosage: 2000 mg, total dose
Indication: Systemic Candida
Start date: 2011-05-23
End date: 2011-06-22
Ambisome
Dosage: 400 mg, uid/qd
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-25
End date: 2011-05-25
Other drugs received by patient: Doripenem Monohydrate; Invanz
|